Capvizr
THE DEAL, AT A GLANCE

OncoC4

From the announcement
01Who is involvedBacked by GBA Fund and supported by existing investorsFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedOncoC4 raised $50M Series BFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersOncoC4 is using Series B capital to advance its cancer treatment pipeline in Healthcare & Life Sciences.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

OncoC4 · Financing Record

Explore source-linked visual explanations for OncoC4. Unsupported claims are withheld while source review continues.

Record 2264 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 2264 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime